___

• KAYNAKLAR
• Verstraelen H, Swidsinski A. The biofilm in bacterial vaginosis: implications for epidemiology, diagnosis and treatment. Current Opinion Infectious Diseases 2013;26: 86-9.
• Zarakolu IŞ. Cinsel yolla bulaşan infeksiyonlar. Hacettepe Tıp Dergisi 2006;37:21-34.
• Barbone F, Austin H, Louv WC, Alexander WJ A. Follow-up study of methods of contraceptions, sexual activity and rates of trichomoniasis, candidiasis and bacterial vaginosis. American Journal Obstetrics and Gynecology 1990;163:510-4.
• Balcı O, Çapar M. Vajinal enfeksiyonlar. Turk J.Obstet Gynecol 2005;2(5):14-20.
• Baron ES, Finegold SM. Baily and Scotts Diagnostic Microbiology. 8th Ed.,St Lousis, the CV Mosby Company 1990:263-270.
• Börekçi M, İngeç M, Aktaş O. Jinekolojik şikâyetleri olan hastalarda vajinal mikroflora üzerine bir araştırma. Atatürk Üniversitesi Tıp Fakültesi Dergisi 2003;35: 57-60.
• Donders G, Vereecken A. Definition of a type of abnormal vaginal flora that is distinct from bacteriel vaginosis: aerobic vaginitis. British Journal Obstetrics Gynecology 2002;109:34-43.
• Mikamo H, Sato Y, Hayasaki Y, Hua YX, Tamaya T. Vaginal microflora in healthy women with Gardnerella vaginalis. Journal of Infection and Chemotherapy 2000;6(3):173-7.
• Koneman EW, Allen SD, Janda WM Schreckenberger PC Winn WC. Diagnostic microbiology Lippincott, 1997:687-749.
• Köksalan H, Esen N, Çağatay M, Tülek N, Mert A. Vaginal akıntı örneklerinden Gardnerella vaginalis’in izolasyonu. Mikrobiyoloji Bülteni 1993;27:191-5.
• Kılıç E, Aslım B. Laktik asit bakterilerinin vajen florasındaki önemi ve probiyotik olarak kullanımı. Orlab On-Line Mikrobiyoloji Dergisi 2003;1(2):70-82.
• Aroutcheva AA, Simoes JA, Behbakht K, Faro S. Gardnerella vaginalis isolated from patients with bacterial vaginosis and from patients with healthy vaginal ecosystems, Clinical Infectious Diseases 2001;33(7):1022-7.
• Can K, Güralp O, Gürleyen H, Çepni İ, Polat E. Evaluation of etiologic agents in bacterial vaginosis by molecular methods. Basic Clinical Sciences 2013;2:154-160.
• Çelik A, Atılgan R, Aygün HB ve ark. Serviko-Vajinal pap smear taramasında Trichomonas vaginalis, Candida ve Gardnerella vaginalis sıklığının yaşa göre değerlendirilmesi. Fırat Tıp Dergisi 2013;18(1):44-7.
• Akılcı İlaç Kullanımı. Erişim Adresi: http://www.akilciilac.gov.tr/?page_id=1068&lang=tr_TR Erişim Tarihi: 10.07.2015.
• Kırkan Ş, Kaya O, Odabaşı AR. Kadınlarda vaginal akıntı örneklerinden Gardnerella vaginalis, Candida albicans ve diğer bakterilerin izolasyonu. Veteriner Hekimleri Mikrobiyoloji Dergisi Elektronik Versiyonu 2002; 2(2): 23-30.
• Greenwood JR, Pickett MJ. Salient features of Haemophilus vaginalis. Journal Clinical Microbiology 1979;200-4.
• Bilgehan, H. Klinik Mikrobiyolojik Tanı. Fakülteler Kitapevi 1995: 2. Basım.
• Watts DH, Krohn MA, Hillier SL, Eschanbach DA. Bacterial vaginosis as a risk factor for postcesarean endometritis. American Journal Obstetrics and Gynecology 1990;75: 52-8.
• Demirezen S. Bacterial vajinitis: general overview. Mikrobiyoloji Bülteni 2003;37:99-104.
• Bump RC. and Buesching WJ. Bacterial vaginosis in virginal and sexually active adolescent females: evidence against exclusive sexual transmission. American Journal Obstetrics and Gynecology 1988;158:935–9.
• Duran N, Çulha G, Çetin M, Zeteroğlu Ş, Güngören A, Hakverdi AU. Genital enfeksiyon şüphesi olan adölesan ve yetişkin kadınlarda enfeksiyon etkenleri. Tıp Araştırmaları Dergisi 2005;3(2):13-9.
• Erdem H, Çetin M, Timuroğlu T, Çetin A, Yanar O, Pasha A. Identification of yeasts in public hospital primary care patients with or without clinical vajinitis. Aust NZJ Obset Gynaecology 2003;43(4):312-6.
• Lippman AS, Jones HE, Luppi CG, Pinho AA, Veras MAMS, Van de Wijgert JHHM. Home-based self-sampling and selftesting for sexually transmitted infections: acceptable and feasible alternatives to provider-based screening in low-income women in São Paulo, Brazil. Sexually Transmitted Diseses 2007;34:421-8.
• Riviera LR, Trenado MQ, Valdez AC, Gonzalez CJC. Prevalencia de vajinitis y vaginosis bacteriana: associación com manifestaciones clínicas, de laboratório y tratamiento. Ginecy Obst Mex 1996;64:26-35.
• Adad SJ, de Lima RV, Sawan ZT. Frequency of Trichomonas vaginalis, Candida sp and Gardnerella vaginalis in cervical- vaginal smears in four different decades. Sao Paulo Medical Journal 2001;119:200-5.
• Sanıç A, Pekbay A, Yanık A, Çaylı R. Vajinal akıntısı bulunan hastalarda Gardenella vaginalis sıklığı. O.M.Ü Tıp Dergisi 1998;15(1):32-6.
• Tomusiak A, Strus M, Heczko PB. Antibiotic resistance of Gardnerella vaginalis isolated from cases of bacterial vaginosis. Ginekol Pol Dec 2011;82:900-4.
• Tosun I, Karaoğlu AS, Ciftçi H ve ark. Biotypes and antibiotic resistance patterns of Gardnerella vaginalis strains isolated from healthy women and women with bacterial vaginosis. Mikrobiyol Bülteni 2007;41(1):21-7.
• Goldstein EJC, Citron DM, Merriam CV, Warren YA, Tyrrell KL, Fernandez HT. In vitro activities of Garenoxacin (BMS 284756) against 108 clinical isolates of Gardnerella vaginalis. Antımıcrobıal Agents And Chemotherapy 2002;46(12):3995-6.
• Akhter S, Sattar H, Miah RA ve ark. Isolation, identification and susceptibility pattern of Gardnerella vaginalis in bacterial vaginosis. Bangladesh Journal of Medical Microbiology 2011;5(1): 8-11.
• Alves P, Castro J, Sousa C, Cereija TB, Cerca N. Gardnerella vaginalis outcompetes 29 other bacterial species isolated from bacterial vaginosis patients in an in vitro biofilm formation model. Journal of Infectious Diseases Advance Access published. March 4. 2014.
• Kaur B, Balgır PP, Mıttu B, Sıngh H, Kumar B, Garg N. Comparasion. Asian Journal of pharmaceutical and clinical research. Academic Sciences 2012;5(3):179-181.
• Hussin SS, Al-Nuzal SMD, Jabbar RA. The susceptibilities of Gardnerella vaginalis isolates from Iraqi hospitals towards various antibiotics and new mixed ligand complexes of 5.5-diphenyl-imidazolidine-2.4-dione with transition metals(II). Al- Mustansiriyah Journal of Science 2013;24(2):39-54.66